ORTEXORTEX News
Tracking NVEC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NV
Trader NoteNVEC

NVEC beats on earnings, shorts ease but still watchful

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 6 May 2026, 21:31

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

NVE Corporation reported fiscal Q4 results after the close on May 6, delivering the clearest catalyst of a strong week. EPS came in at $1.02, up from $0.80 a year ago. Revenue hit $7.65 million, ahead of the prior-year $7.27 million. The company simultaneously declared a quarterly cash dividend. The stock had already moved hard into the print — up 7.4% on the week and 22.7% over the past month to close at $84.98 — making this an earnings-confirmed rally rather than a speculative one.

Short sellers have been reducing their exposure into the strength, though they haven't abandoned the trade. Short interest dropped from a recent peak of around 322,000 shares in mid-April to roughly 294,000 today — a decline of about 8.5% from that high. As a percentage of the free float, the position now reads at approximately 6.1%, still meaningful for a micro-cap spintronics name. The pace of reduction has been gradual rather than a sudden short-side panic. The ORTEX short score, at 47.3 and ticking up from 46.5 at the start of the week, reflects a position that is moderating but not capitulating.

The borrow market tells a relaxed story. Cost to borrow has edged up 27% on the week but remains exceptionally cheap at just 0.47% annualised — a level that imposes no real pain on a short position. Availability in the lending pool is ample: with utilisation around 6% against a 52-week peak of 22.8%, there is no squeeze pressure visible. Shorts can stay, add, or cover with minimal friction. That combination of modest short interest, low cost, and high availability argues against any near-term mechanically-driven covering.

The peer group had a strong week across the board. MRAM was the standout, surging 49.5% on the week — an outlier that likely reflects stock-specific news rather than sector momentum. NVTS added 16.1% and PDFS gained 15.6%. NVEC's 7.4% weekly gain looks restrained by comparison, though that context cuts both ways: NVEC moved first and with more consistency over the month, while peers may be playing catch-up to a broader small-cap semiconductor re-rating.

On the institutional side, the ownership structure is concentrated. Defiance ETFs and Penserra Capital Management each hold approximately 11.4% of shares — passive and semi-passive vehicles whose flows track index demand rather than fundamental conviction. Vanguard and BlackRock together account for a further 16%. Renaissance Technologies held 3.7% as of December, a name worth noting given its quantitative nature. The tight institutional base means trading in NVEC remains thin and event-driven; a strong earnings print like today's can move the stock substantially on modest volume.

The prior two earnings releases support that observation. NVEC gained 4.7% the day after January's Q3 release, and 11.2% the day after the Q2 print in October — the latter followed by a further 5.3% over the subsequent five days. With fiscal Q4 results now out and a quarterly dividend reaffirmed, the immediate catalyst has cleared. What matters next is whether the EPS momentum — now visibly accelerating — draws fresh institutional attention to a name that has historically traded in a narrow band and rewarded patient holders.

Stocks in this article

See the live data behind this article on ORTEX.

Open NVEC on ORTEX →

How this article was generated

Generated
6 May 2026, 21:35
Data as of
6 May 2026, 21:31
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationEarningsInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.